OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson’s disease
Zahra Hadadianpour, Farangis Fatehi, Fateme Ayoobi, et al.
Neurological Research (2017) Vol. 39, Iss. 9, pp. 845-851
Closed Access | Times Cited: 45
Zahra Hadadianpour, Farangis Fatehi, Fateme Ayoobi, et al.
Neurological Research (2017) Vol. 39, Iss. 9, pp. 845-851
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Neuroprotective effects of Ellagic acid against acrylamide-induced neurotoxicity in rats
Mehdi Goudarzi, Mohammad Amin Mombeini, Iman Fatemi, et al.
Neurological Research (2019) Vol. 41, Iss. 5, pp. 419-428
Closed Access | Times Cited: 79
Mehdi Goudarzi, Mohammad Amin Mombeini, Iman Fatemi, et al.
Neurological Research (2019) Vol. 41, Iss. 5, pp. 419-428
Closed Access | Times Cited: 79
Orexin pathway in Parkinson’s disease: a review
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6107-6120
Closed Access | Times Cited: 23
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6107-6120
Closed Access | Times Cited: 23
miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy
Hui Dong, Jiahui Yan, Ping Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116123-116123
Open Access | Times Cited: 11
Hui Dong, Jiahui Yan, Ping Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116123-116123
Open Access | Times Cited: 11
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
Meifang Liu, Yan Xue, Cui Liu, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 55
Meifang Liu, Yan Xue, Cui Liu, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 55
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Phenethyl Isothiocynate attenuates Parkinson's disease and improves performance in Hanging wire, Rotarod and Actophotometer Test & Dopamine levels in rats via inhibiting HDAC-1
Nikhil Eknath More, Angel Godad
Brain Disorders (2025), pp. 100183-100183
Open Access
Nikhil Eknath More, Angel Godad
Brain Disorders (2025), pp. 100183-100183
Open Access
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Therapeutic effect of formononetin in 6-OHDA induced Parkinson disease in rats
Tanvi Pingale, Girdhari Lal Gupta
Inflammopharmacology (2025)
Closed Access
Tanvi Pingale, Girdhari Lal Gupta
Inflammopharmacology (2025)
Closed Access
Development and evaluation of S-carboxymethyl-L-cystine-loaded solid lipid nanoparticles for Parkinson’s disease in murine and zebrafish models
Shannon D Almeida, Sameera Hammigi Ramesh, G. Radhakrishna, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Shannon D Almeida, Sameera Hammigi Ramesh, G. Radhakrishna, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Predicting susceptibility and resilience in an animal model of post-traumatic stress disorder (PTSD)
Paola Colucci, Enrico Marchetta, Giulia Federica Mancini, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Paola Colucci, Enrico Marchetta, Giulia Federica Mancini, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Orexin A alleviates neuroinflammation via OXR2/CaMKKβ/AMPK signaling pathway after ICH in mice
Tao Li, Weilin Xu, Jinsong Ouyang, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Tao Li, Weilin Xu, Jinsong Ouyang, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Association between Sleep, Alzheimer’s, and Parkinson’s Disease
S. Matsumoto, Tomomi Tsunematsu
Biology (2021) Vol. 10, Iss. 11, pp. 1127-1127
Open Access | Times Cited: 30
S. Matsumoto, Tomomi Tsunematsu
Biology (2021) Vol. 10, Iss. 11, pp. 1127-1127
Open Access | Times Cited: 30
Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats
Cui Liu, Yan Xue, Meifang Liu, et al.
Journal of Neurochemistry (2018) Vol. 147, Iss. 3, pp. 380-394
Open Access | Times Cited: 28
Cui Liu, Yan Xue, Meifang Liu, et al.
Journal of Neurochemistry (2018) Vol. 147, Iss. 3, pp. 380-394
Open Access | Times Cited: 28
Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential
Cui Liu, Yan Xue, Meifang Liu, et al.
Neurochemistry International (2020) Vol. 138, pp. 104754-104754
Closed Access | Times Cited: 25
Cui Liu, Yan Xue, Meifang Liu, et al.
Neurochemistry International (2020) Vol. 138, pp. 104754-104754
Closed Access | Times Cited: 25
Orexins role in neurodegenerative diseases: From pathogenesis to treatment
Derbew Fikadu Berhe, Abadi Kahsu Gebre, Brhane Teklebrhan Assefa
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172929-172929
Closed Access | Times Cited: 21
Derbew Fikadu Berhe, Abadi Kahsu Gebre, Brhane Teklebrhan Assefa
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172929-172929
Closed Access | Times Cited: 21
The role of orexin in Parkinson's disease
Alisha Braun, Jim Manavis, Akihiro Yamanaka, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 3
Open Access | Times Cited: 2
Alisha Braun, Jim Manavis, Akihiro Yamanaka, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 3
Open Access | Times Cited: 2
Orexin in Respiratory and Autonomic Regulation, Health and Diseases
Savannah Barnett, Aihua Li
Comprehensive physiology (2020), pp. 345-363
Closed Access | Times Cited: 19
Savannah Barnett, Aihua Li
Comprehensive physiology (2020), pp. 345-363
Closed Access | Times Cited: 19
Orexinergic System in Neurodegenerative Diseases
Qinqin Wang, Fei Cao, Yili Wu
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 16
Qinqin Wang, Fei Cao, Yili Wu
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 16
Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson’s disease
Ying Wang, An-Qi Chen, Yan Xue, et al.
AJP Cell Physiology (2019) Vol. 317, Iss. 4, pp. C800-C812
Open Access | Times Cited: 18
Ying Wang, An-Qi Chen, Yan Xue, et al.
AJP Cell Physiology (2019) Vol. 317, Iss. 4, pp. C800-C812
Open Access | Times Cited: 18
The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson’s disease rat model
Iman Fatemi, Abbas Abdollahi, Ali Shamsizadeh, et al.
Acta Neuropsychiatrica (2020) Vol. 33, Iss. 1, pp. 15-21
Closed Access | Times Cited: 15
Iman Fatemi, Abbas Abdollahi, Ali Shamsizadeh, et al.
Acta Neuropsychiatrica (2020) Vol. 33, Iss. 1, pp. 15-21
Closed Access | Times Cited: 15
Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model
Luíz M. Oliveira, Elisandra Henrique, Isabella B. Bustelli, et al.
Experimental Neurology (2019) Vol. 323, pp. 113110-113110
Closed Access | Times Cited: 14
Luíz M. Oliveira, Elisandra Henrique, Isabella B. Bustelli, et al.
Experimental Neurology (2019) Vol. 323, pp. 113110-113110
Closed Access | Times Cited: 14
Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
Sachin Kumar, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2141-2153
Closed Access | Times Cited: 12
Sachin Kumar, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2141-2153
Closed Access | Times Cited: 12
Swimming improves cognitive reserve in ovariectomized rats and enhances neuroprotection after global cerebral ischemia
Meng Zhang, Yating Zhai, Yaping Sun, et al.
Brain Research (2018) Vol. 1692, pp. 110-117
Closed Access | Times Cited: 14
Meng Zhang, Yating Zhai, Yaping Sun, et al.
Brain Research (2018) Vol. 1692, pp. 110-117
Closed Access | Times Cited: 14
Neuroprotective and antihyperalgesic effects of orexin-A in rats with painful diabetic neuropathy
Seddigheh Niknia, Ayat Kaeidi, Mohammad Reza Hajizadeh, et al.
Neuropeptides (2018) Vol. 73, pp. 34-40
Closed Access | Times Cited: 13
Seddigheh Niknia, Ayat Kaeidi, Mohammad Reza Hajizadeh, et al.
Neuropeptides (2018) Vol. 73, pp. 34-40
Closed Access | Times Cited: 13
